Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia
✍ Scribed by Anita Schmitt; Peter Reinhardt; Iwona Hus; Jacek Tabarkiewicz; Jacek Roliñski; Thomas Barth; Krzysztof Giannopoulos; Anna Dmoszyñska; Markus Wiesneth; Michael Schmitt
- Book ID
- 109143715
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 188 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0372-1248
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Although a second stem cell transplantation (SCT) can be used as salvage therapy in patients with relapsing leukemia after SCT, most of these patients have a poor outcome. We tried clinical vaccination using monocyte-derived dendritic cells (DCs) pulsed with leukemic lysates to treat relapsing acute
Clinical application of immunotherapy for acute myeloid leukemia (AML) requires the efficient induction of dendritic cells (DCs) from AML blast cells using in vitro culture. We examined the effect of autologous serum on the properties of leukemic DCs derived from leukemic cells of AML patients by cu
## Abstract Specific immunotherapies for patients with acute myeloid leukemia (AML) using leukemia‐associated antigens (LAA) as target structures might be a therapeutic option to enhance the graft‐__vs__.‐leukemia effect observed after allogeneic stem cell transplantation or to prolong a complete r